News for hackers. Stuff that matters.
Re:FDA Approves First Gene Therapy Treatment of Duchenne Mus... by Jorge1o1 on Thursday June 22, 2023 @10:00PM (#36441925)
Interestingly, after months of chopping along at the whims of the FDA, the stock actually sold off a little today after the news came out at 2pm.[1]

A good example of what it means for news to to be "already priced in," and how in fact, too many traders in a name can overcrowd it and destroy the alpha. It's like game theory.

[1] https://yhoo.it/3pbC6aB

Re:FDA Approves First Gene Therapy Treatment of Duchenne Mus... by ninja3925 on Thursday June 22, 2023 @10:06PM (#36441954)
I somewhat understand your point but the facts imperfectly support it. If information was already priced in, say 90% chance of success, a positive outcome would still provide a lift from the remaining 10%.

The decrease sounds like something else is going on.

Re:FDA Approves First Gene Therapy Treatment of Duchenne Mus... by mhluongo on Thursday June 22, 2023 @10:33PM (#36442129)
"Buy the rumor, sell the news"
Re:FDA Approves First Gene Therapy Treatment of Duchenne Mus... by throwaway2037 on Friday June 23, 2023 @02:09AM (#36443412)
2% is nothing for a single name stock. Who cares. It is just noise.

Looking at the close price history here: https://www.google.com/search?q=SRPT+price&rlz=1C1GCEB_enJP1...

Overall, the last one year has been pretty flat for this stock.

Re:FDA Approves First Gene Therapy Treatment of Duchenne Mus... by m3kw9 on Thursday June 22, 2023 @10:45PM (#36442203)
It’s more like ppl sell because they know bull with this environment will keep buying till news hits
Re:FDA Approves First Gene Therapy Treatment of Duchenne Mus... by fullburley on Friday June 23, 2023 @12:48AM (#36442905)
The approved label reduced access to 4 and 5 year olds, shrinking the market opportunity in the short term.
Re:FDA Approves First Gene Therapy Treatment of Duchenne Mus... by Cthulhu_ on Friday June 23, 2023 @03:31AM (#36443888)
Stock prices have nothing to do with the successes or failures of a company, and everything with hype, marketing, and mainstream appeal. Same with cryptocurrencies and the likes. It's not a rational market, but everyone talks about it like it is.